Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

US Patent 11919910 · Granted Mar 5, 2024

Estimated economic value: $4,831,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral heterocyclic compounds2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods2025
Intelligent machining line for pipe sections and method for machining same2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there2025